Glenmark Pharmaceuticals Limited Walk-in Interview 2021 D. Pharma / Diploma/ B.Sc. Regular,B. Pharma / M. Pharma / M.Sc. Regular.,ITI for Packing Department At goa.Glenmark Pharmaceuticals Limited Notification full detailes below.Interested candidate can apply on Eswar.R@glenmarkpharma.com along with updated resume.Interested and eligible candidates can attend interview on scheduled time and venue.
Important Vacancy details:
- Company name: Glenmark Pharmaceuticals Limited
- Post Name: Packing Department
- Qualification :D. Pharma / Diploma/ B.Sc. Regular,B. Pharma / M. Pharma / M.Sc. Regular.,ITI
- Experience:04-9 Years
- Location: goa
- Salary:NA
- Openings: NA
- Contact Number:NA
- Selection Process: The selection will be based on Interview..
Job Description:
Virtual Walk-In Interview For OSD Packing Department on Saturday 12-06-2021.
1. Packing Line Supervisors : Blister Packing / Bottle Packing.
Designation : Senior Officers
Qualification : B. Pharma / M. Pharma / M.Sc. Regular.
Experience : 3 – 5 Years
Note : Regulatory Audit Experience is a Must (USFDA/MHRA)Roles and Responsibilities
2. Packing Operators – Officers / Junior Officers
Officers : CVC Primary Operator (Trouble Shooter)
Qualification : D. Pharma / Diploma/ B.Sc. Regular.
Experience : 5 – 9 Years
Junior Officers : BQS Primary (Trouble Shooter) / Cartonator Operators ( IC-150)
Qualification : I.T.I
Experience : 4 – 9 Years
Interested Candidates can Send Resume to Eswar.R@glenmarkpharma.com with basic details of Total Experience / Present CTC / Expected CTC / Notice Period.
About Company :Glenmark Pharmaceuticals Limited [Glenmark] is an India-based growing pharmaceutical company headquartered at Mumbai [formerly, Bombay]. Incorporated in 1977, the Company is focused on the manufacture and marketing of formulation products and active pharmaceutical ingredients [API] in India as well as globally and enjoys a diversified and growing presence in regulated and developing international markets. Over the past five years, the Company has also catalysed its growth through investment in dedicated research and development including cutting-edge New Chemical Entity [NCE] research.